Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review

  • ID: 4418478
  • SWOT Analysis
  • 36 pages
  • GlobalData
1 of 5
Jiangsu Engrail Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Jiangsu Engrail Medicine Co Ltd (Jiangsu Engrail) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes anti neoplastic products, anti-tumor drugs, surgical drugs and contrast agents. The company offers products in central nervous system (CNS), musculoskeletal, metabolic, hematologic, infection, respiratory, cardiovascular, dermatology, gastrointestinal, cancer and other areas. Jiangsu Engrail has manufacturing and R&D facilities in Shanghai, Chengdu, Quzhou and Lianyungang, China. The company offers its products through sales and distribution network spread across China. Jiangsu Engrail is headquartered in Lianyungang, Jiangsu Province, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Section 1 - About the Company
Jiangsu Hengrui Medicine Co Ltd - Key Facts
Jiangsu Hengrui Medicine Co Ltd - Key Employees
Jiangsu Hengrui Medicine Co Ltd - Major Products and Services
Jiangsu Hengrui Medicine Co Ltd - History
Jiangsu Hengrui Medicine Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Section 2 – Company Analysis
Company Overview
Jiangsu Hengrui Medicine Co Ltd - Business Description
Business Segment: Other Business
Performance
Business Segment: Pharmaceutical Manufacturing
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Foreign
Performance
R&D Overview
Jiangsu Hengrui Medicine Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Jiangsu Hengrui Medicine Co Ltd - Strengths
Jiangsu Hengrui Medicine Co Ltd - Weaknesses
Jiangsu Hengrui Medicine Co Ltd - Opportunities
Jiangsu Hengrui Medicine Co Ltd - Threats
Jiangsu Hengrui Medicine Co Ltd - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary

Section 5 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Jiangsu Hengrui Medicine Co Ltd, Key Facts
Jiangsu Hengrui Medicine Co Ltd, Key Employees
Jiangsu Hengrui Medicine Co Ltd, Major Products and Services
Jiangsu Hengrui Medicine Co Ltd, History
Jiangsu Hengrui Medicine Co Ltd, Subsidiaries
Jiangsu Hengrui Medicine Co Ltd, Joint Venture
Jiangsu Hengrui Medicine Co Ltd, Key Competitors
Jiangsu Hengrui Medicine Co Ltd, Ratios based on current share price
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios
Jiangsu Hengrui Medicine Co Ltd, Interim Ratios
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Jiangsu Hengrui Medicine Co Ltd, Performance Chart (2013 - 2017)
Jiangsu Hengrui Medicine Co Ltd, Ratio Charts
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sundia MediTech Company Ltd
  • Skystar Bio-Pharmaceutical Company
  • Sinopharm Group Co Ltd
  • Chongqing Lummy Pharmaceutical Co Ltd
  • Anhui Anke Biotechnology (Group) Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll